These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 20307356

  • 1. Heat shock protein 70 and cellular disturbances in cochlear cisplatin ototoxicity model.
    García-Berrocal JR, Nevado J, González-García JA, Sánchez-Rodríguez C, Sanz R, Trinidad A, España P, Citores MJ, Ramírez-Camacho R.
    J Laryngol Otol; 2010 Jun; 124(6):599-609. PubMed ID: 20307356
    [Abstract] [Full Text] [Related]

  • 2. Endogenous protection against oxidative stress caused by cisplatin: role of superoxide dismutase.
    González-García JA, Nevado J, García-Berrocal JR, Sánchez-Rodríguez C, Trinidad A, Sanz R, Ramírez-Camacho R.
    Acta Otolaryngol; 2010 Apr; 130(4):453-7. PubMed ID: 19883181
    [Abstract] [Full Text] [Related]

  • 3. Caspase inhibitor facilitates recovery of hearing by protecting the cochlear lateral wall from acute cochlear mitochondrial dysfunction.
    Mizutari K, Matsunaga T, Kamiya K, Fujinami Y, Fujii M, Ogawa K.
    J Neurosci Res; 2008 Jan; 86(1):215-22. PubMed ID: 17722114
    [Abstract] [Full Text] [Related]

  • 4. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
    Cooper LB, Chan DK, Roediger FC, Shaffer BR, Fraser JF, Musatov S, Selesnick SH, Kaplitt MG.
    Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
    [Abstract] [Full Text] [Related]

  • 5. Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK.
    Lee JS, Kang SU, Hwang HS, Pyun JH, Choung YH, Kim CH.
    Toxicol Lett; 2010 Dec 15; 199(3):308-16. PubMed ID: 20883750
    [Abstract] [Full Text] [Related]

  • 6. HSP-70 as a nonspecific early marker in cisplatin ototoxicity.
    Ramírez-Camacho R, Citores MJ, Trinidad A, Verdaguer JM, García-Berrocal JR, Marero AM, Puente A, González-García JA, Vargas JA.
    Acta Otolaryngol; 2007 Jun 15; 127(6):564-7. PubMed ID: 17503223
    [Abstract] [Full Text] [Related]

  • 7. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
    Huang X, Whitworth CA, Rybak LP.
    Otol Neurotol; 2007 Sep 15; 28(6):828-33. PubMed ID: 17450108
    [Abstract] [Full Text] [Related]

  • 8. The anticancer drug cisplatin induces an intrinsic apoptotic pathway inside the inner ear.
    García-Berrocal JR, Nevado J, Ramírez-Camacho R, Sanz R, González-García JA, Sánchez-Rodríguez C, Cantos B, España P, Verdaguer JM, Trinidad Cabezas A.
    Br J Pharmacol; 2007 Dec 15; 152(7):1012-20. PubMed ID: 17906689
    [Abstract] [Full Text] [Related]

  • 9. Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss.
    Wang J, Ladrech S, Pujol R, Brabet P, Van De Water TR, Puel JL.
    Cancer Res; 2004 Dec 15; 64(24):9217-24. PubMed ID: 15604295
    [Abstract] [Full Text] [Related]

  • 10. Ebselen attenuates cisplatin-induced ROS generation through Nrf2 activation in auditory cells.
    Kim SJ, Park C, Han AL, Youn MJ, Lee JH, Kim Y, Kim ES, Kim HJ, Kim JK, Lee HK, Chung SY, So H, Park R.
    Hear Res; 2009 May 15; 251(1-2):70-82. PubMed ID: 19286452
    [Abstract] [Full Text] [Related]

  • 11. Correlation of increased activities of Na+, K+-ATPase and Ca2+-ATPase with the reversal of cisplatin ototoxicity induced by D-methionine in guinea pigs.
    Cheng PW, Liu SH, Hsu CJ, Lin-Shiau SY.
    Hear Res; 2005 Jul 15; 205(1-2):102-9. PubMed ID: 15953519
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Time response of carboplatin-induced hearing loss in rat.
    Husain K, Scott B, Whitworth C, Rybak LP.
    Hear Res; 2004 May 15; 191(1-2):110-8. PubMed ID: 15109710
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect.
    Bielefeld EC, Tanaka C, Chen GD, Coling D, Li M, Henderson D, Fetoni AR.
    Anticancer Drugs; 2013 Jan 15; 24(1):43-51. PubMed ID: 22828384
    [Abstract] [Full Text] [Related]

  • 18. Protection against cisplatin-induced ototoxicity by adeno-associated virus-mediated delivery of the X-linked inhibitor of apoptosis protein is not dependent on caspase inhibition.
    Chan DK, Lieberman DM, Musatov S, Goldfein JA, Selesnick SH, Kaplitt MG.
    Otol Neurotol; 2007 Apr 15; 28(3):417-25. PubMed ID: 17211286
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Expression of heat shock protein 70 mRNA in guinea pig cochlea with ototoxicity of gentamicin].
    Ni YQ, Tang H, Fu WS.
    Sheng Li Xue Bao; 2005 Jun 25; 57(3):328-32. PubMed ID: 15968427
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.